Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mohamed Mofreh Bakr
Observed name:
Bakr, Mohamed Mofreh
Institutions:
National Organization for Drug Control and Research,
Egyptian Drug Authority
Observed institutions:
National Organization for Drug Control and Research,
Egyptian Drug Authority
ORCID:
0009-0007-1037-1058
Observed ORCID:
0009-0007-1037-1058
OpenAlex ID:
A5029036988
Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19
2021
·
Dina B. Mahmoud
, Mohamed Mofreh Bakr
, et al.
·
AAPS PharmSciTech
·
63
PDF
In Situ Hexosomal Gel as a Promising Tool to Ameliorate the Transnasal Brain Delivery of Vinpocetine: Central Composite Optimization and In Vivo Biodistribution
2020
·
Mohamed Mofreh Bakr
, Marwa Hassan Shukr
, et al.
·
Journal of Pharmaceutical Sciences
·
33
Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances
2024
·
Aprameya Prasad
, Mohamed Mofreh Bakr
, et al.
·
Journal of drug targeting
·
16
Pomegranate extract-loaded surfactant-free zein nanoparticles as a promising green approach for hepatic cancer: optimization and in vitro cytotoxicity
2024
·
Salma Mohsen
, Mohamed Mofreh Bakr
, et al.
·
Future Journal of Pharmaceutical Sciences
·
8
Celecoxib or diallyl trisulfide topical emulgels, alone or in combination, reduce pruritus and inflammatory cascades in a BALB/c mouse model of imiquimod-induced psoriasis
2026
·
Maha M. Kamel
, Hala F. Zaki
, et al.
·
Pharmacia
PDF
Correction: Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19
2026
·
Dina B. Mahmoud
, Mohamed Mofreh Bakr
, et al.
·
AAPS PharmSciTech
PDF
Show more works
View as search
Works count:
8
Citation count:
120
H-index:
4
I10-index:
3
Year
Topic
Type